Dosing Vincristine in Dose-Adjusted EPOCH-R: To Cap or Not to Cap?

J Clin Oncol. 2019 Nov 1;37(31):2952. doi: 10.1200/JCO.19.01259. Epub 2019 Sep 18.

Authors

Taylor M Weis¹, Anthony J Perissinotti¹, Victoria R Nachar¹, Anna M Brown¹, Tycel J Phillips¹, Bernard L Marini¹

Affiliation

¹ Taylor M. Weis, PharmD; Anthony J. Perissinotti, PharmD; Victoria R. Nachar, PharmD; Anna M. Brown, PharmD; Tycel J. Phillips, MD; and Bernard L. Marini, PharmD, University of Michigan, Ann Arbor, MI.

PMID: 31532723
DOI: 10.1200/JCO.19.01259

No abstract available

Publication types

Letter
Kommentar

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Doxorubicin
Etoposide
Humans
Lymphoma, Large B-Cell, Diffuse*
Prednisone
Vincristine

Substances

Vincristine
Etoposide
Doxorubicin
Cyclophosphamide
Prednisone

Supplementary concepts

EPOCH protocol